INTRODUCTION
Lysosomes are a major intracellular site for the degradation of a wide variety of macromolecules, including proteins, complex carbohydrates, glycolipids and nucleic acids. Many of the metabolites generated as a result of lysosomal macromolecule breakdown are transported back into the cytosol, where they can be reutilized for the synthesis of new macromolecules or participate in various metabolic pathways. The role of lysosomes in supporting cellular activities is especially important under conditions of nutritional deprivation, in which the lysosome can be viewed as a major recycling centre for providing the basic building blocks for synthesis of essential proteins, nucleic acids, carbohydrates and lipids necessary for cell survival.
Lysosomes contain a repertoire of enzymes capable of degrading nucleic acids completely to their constituent nucleosides [1] [2] [3] [4] [5] . Under conditions of nutritional deprivation, -65 % of total rat liver cytoplasmic RNA is degraded per day, with 70-85 % of this degradation occurring within the lysosomal compartment [6, 7] . The nucleosides that result from nucleic acid breakdown within lysosomes are returned to the cytosol by the lysosomal nucleoside-transport system [8] . In the case of adenosine, however, substantial deamination of this nucleoside to inosine occurs within human fibroblast lysosomes [8] . In the present paper, we describe the characteristics of the adenosine deaminase (ADA) activity present in human fibroblast lysosomes and discuss how lysosomal compartmentalization of adenosine deaminase may be important for maintaining cellular energy requirements under conditions when cytosolic adenosine levels are low.
EXPERIMENTAL
Cell culture and preparation of Percoll-purffled lysosomes Normal human fetal skin fibroblasts (GMOOlOA) and the ADApropylidene-adenosine (2.5 mM) and erythro-9-(2-hydroxy-3-nonyl)adenine (0.2 mM) inhibited lysosomal ADA by > 97 %. In contrast, 2.5 mM S-adenosyl-L-homocysteine and cytosine were poor inhibitors. Nearly all lysosomal ADA activity is eluted as a high-molecular-mass protein (> 200 [9, 10] . When nearly confluent, human fibroblast monolayers were routinely split 1 :4 by using a mixture of collagenase, trypsin and chicken serum (CTC) as described previously [11] , and were not used beyond passage 18. Lysosomes were prepared from six to seven roller bottles of nearly confluent human fibroblasts by centrifugation on Percoll density gradients as described previously [12, 13] , and stored at -20°C in -0. 
RESULTS
In a previous investigation of nucleoside transport by human fibroblast lysosomes, we had observed that a substantial portion of the radiolabelled adenosine taken up by fibroblast lysosomes was converted into inosine [8] . After a 2.5 min uptake of 1 mM [3H]adenosine, approx. 15 % of the radioactivity recovered from human fibroblast lysosomes was found to be inosine, and after [3H]adenosine uptakes of 15-20 min inosine accounted for the great majority of the total radioactivity recovered from lysosomes. The goal of the present investigation was to examine the characteristics of this adenosine-deaminating activity present in human fibroblast lysosomes and to determine if this enzyme differs from other ADA activities which have been characterized previously.
In previous subcellular fractionations of the human fibroblast, only lysosomes have been found to sediment in the bottom third of 30-40 % Percoll density gradients, as judged by the appearance of this fraction on electron micrographs and by the distribution of the marker enzymes 8-hexosaminidase, succinate dehydrogenase, galactosyltransferase and 5'-nucleotidase [13, [15] [16] [17] . The purity of this dense Percoll fraction as being that of lysosomes is further substantiated by the characterization of a large number of lysosomal transport systems from this fraction, which display properties that significantly differ from their analogous counterparts on other cellular membranes [18] . To demonstrate the presence of ADA activity within human fibroblast lysosomes, fibroblasts were lysed, nuclei were removed by centrifugation, and a granular fraction was obtained which contained 13 % of the total human fibroblast ADA activity. When the granular fraction was centrifuged on a 31 %-Percoll density gradient, much of the ADA activity co-migrated with the lysosomal marker enzyme ,J-hexosaminidase, with most of both of these enzymes being found in the bottom third of the Percoll density gradient ( Figure 1 ). Some ADA activity is also observed at the top of the Percoll gradient, which may be non-vesicularized enzyme or enzyme associated with a buoyant organelle such as endosomes or plasma-membrane vesicles. ADA activity has been found to be associated with the plasma membrane of various cells [19] [20] [21] [22] [23] [24] . The ADA characterized in the present investigation was taken only from the bottom third of the Percoll density gradients, in which only lysosomes have been found.
Human fibroblasts have been shown to contain a large-and a small-molecular-mass form of ADA [9, 10, 25, 26] . With confluent Lysosomal lysate (/,u) Figure (Figure 2 ). In addition, a very low level of ADA activity was observed in some of the fractions eluted after the high-molecular-mass ADA peak. These smaller ADA activities may represent ADA species generated from the lysosomal degradation of the high-molecularmass ADA form. Daddona et al. [10] have shown previously that the ADAdeficient human fibroblast cell line, GM469, contains -2 % of the normal level of ADA activity. We quantified the total amount of ADA activity in lysosomes from GM469 fibroblasts, and found that lysosomal ADA activity is also greatly decreased in this cell line to -5 % of that found in the GMOOIOA normal human fibroblast cell line (results not shown). These results suggest that the catalytic portion of lysosomal ADA is derived from the same gene as that which is defective in ADA deficiency (i.e. that coding for the 38 kDa catalytic subunit).
Since a focus of this study was to define the characteristics of ADA functioning within the environment of the lysosomal compartment, all assays were performed at pH 5.5, which is near the intralysosomal pH previously reported for human fibroblast lysosomes [29] . Lysosomal ADA activity was found to be directly dependent on the amount of lysosomal material added to incubation mixtures (Figure 3) of adenosine demonstrates saturability of the enzyme ( Figure  4a ). The Lineweaver-Burk plot is linear, suggesting that lysosomal adenosine deamination is catalysed by only one enzyme, with a Km of 37 + 4 ,M at 25°C and pH 5.5 (Figure 4b ). This Km is somewhat lower than the Km of 60-65 ,M reported previously for other human fibroblast ADA activities measured at pH 7.5 and 37°C [9] . A Vmax of 14.8 pmol of inosine formed/min per unit of N-acetyl-,8-hexosaminidase was found for lysosomal ADA at pH 5.5 and 25°C. The Vmax of lysosomal ADA varies with pH in a manner similar to that reported for other ADA activities [30] [31] [32] [33] [34] , being greatest in the neutral pH range pH 7-8, and declining steadily over the range pH 7-4, with little or no enzymic activity observed at pH values less than 4 ( Figure 5 ). This pH profile coincides well with recent X-ray-crystallographic data suggesting that the side-chain carboxyl group ofan aspartate residue located in the active site of ADA is important for the catalytic mechanism of this enzyme [35] . Since this carboxyl group is located in a highly hydrophobic environment [35] , its PKa is expected to be higher than for an aspartate side-chain carboxyl group free in aqueous solution.
Hirschhorn et al. [9] have shown that a 60% inactivation of ADA activity occurs when human fibroblast ADA is incubated at 56°C for 80 min. In contrast, the residual ADA activity present in several different ADA-deficient fibroblast cell lines exhibits a much greater heat-stability, losing only 10-20% of activity when incubated at 56°C for 80 min [9] . Lysosomal ADA from the normal human fibroblast used in the present study also was found to be very heat-stable, losing 30% of its initial activity when incubated at 65°C for 80 min ( Figure 6 ).
In addition to the existence of ADA within human cells, an aminohydrolase capable of deaminating adenosine has been shown to be present in human spleen tissue and B-lymphoblast cells [31, 36] . This aminohydrolase displays a Km of 2-3 mM for adenosine which is 40-50 times higher than that of ADA. The aminohydrolase also exhibits a molecular-mass of 92-110 kDa, appears to be extremely heat-stabile at 68°C, and is not inhibited by 0.2 mM EHNA, which has been shown to inhibit ADA strongly [31] . To assess the specificity of the human fibroblast lysosomal ADA activity, we analysed the ability of various nucleobase, nucleoside and nucleotide analogues to inhibit lysosomal adenosine-deaminating activity (Table 1) . Deoxycoformycin (0.02 mM), coformycin (2.5 mM), adenosine (2.5 mM), 2'-deoxyadenosine (2.5 mM), 6-methylaminopurine riboside (2.5 mM) and 2',3'-isopropylidene-adenosine (2.5 mM) strongly inhibited lysosomal ADA activity by more than 97 %. EHNA inhibited the lysosomal enzyme by > 98 %, thus further indicating that lysosomal adenosine deamination is not due to the action of a non-specific aminohydrolase. The pyrimidine cytosine (2.5 mM) and S-adenosyl-L-homocysteine (2.5 mM) poorly inhibited lysosomal ADA, by < (Table 2 ). Hg2+ and Cu2+ were found to inhibit lysosomal ADA completely, whereas the other bivalent cations had no effect on lysosomal ADA. The strong inhibitory action of Hg2+ and Cu2+ on both lymphoblast ADA and lysosomal ADA may reflect the binding of these bivalent cations to a thiol group that has been previously implicated as being important for ADA activity [33, 34, 37] or may inhibit the catalytic function of the essential active-site Zn2+ ion of ADA [35] . It is conceivable that the other bivalent cations inhibit the small form of ADA at pH 7.4 by binding in part to side-chain carboxyl groups which are ionized at pH 7.4 but not at pH 5.5, or bind to sites on the enzyme which are accessible in the small-molecular-mass form of lymphoblast ADA but not in the large-molecular-mass form of lysosomal ADA.
Lucarini et al. [38] have reported that human erythrocyte acid phosphatase activity is stimulated as much as 160% by 4.2 mM inosine. In view of these findings, we tested whether 4.2 mM inosine could modulate human fibroblast lysosome acid phosphatase activity, thereby implicating a role for ADA in upregulating lysosomal phosphatase activity. In contrast with the results of Lucarini et al., we did not observe any significant effect Table 1 Inhibition of lysosomal ADA by various nucleoside and nucleobase  analogues  Lysosomal material was incubated with [9, 10, 19, 25] that receptor-mediated endocytosis of exogenous ADA does not significantly contribute to the total ADA content of human fibroblasts. It should be noted, however, that in four separate experiments when GM469 fibroblasts were cultured for 13 days or more in media containing 20 % fetal-calf serum with several changes of media during this time, the amount of lysosomal ADA activity recovered from these cells was greatly increased, and instead of being 2 % of the normal range, the lysosomal ADA activity was now at the same level as that found in normal human fibroblasts. If GM469 fibroblasts were cultured for 13 days in media containing 20 % fetal-calf serum and then placed in media containing 10% horse serum for 2 days, the amount of lysosomal ADA recovered from the cells returned to its low level of approx. 2 % of the normal range. The mechanism by which culturing GM469 fibroblasts in 20 % fetal-calf serum leads to a large increase in the lysosomal ADA level within this cell type is not known at present, and whether that mechanism is physiologically relevant to how ADA is delivered to lysosomes in normal human fibroblasts is not apparent. As one possibility, the enhancement of lysosomal ADA observed in cells grown in 20 % fetal-calf serum, but not in 10 % fetal-calf serum, may reflect the difference in the amount of ADA delivered to lysosomes via pinocytosis or plasma-membrane internalization versus the rate of degradation of ADA within the lysosomal compartment.
Lardeux and Mortimore [6] have shown that, in perfused rat liver under conditions of nutritional deprivation, approx. 65 % of the total rat liver cytoplasmic RNA is degraded per day, with 70 85 % of this turnover occurring within the lysosomal compartment. In this context, lysosomes clearly play a central role in generating nucleosides that can be re-utilized for the synthesis of nucleic acids necessary for cell survival. Moreover, inosine can serve as a fuel for the production of ATP to drive energyrequiring reactions within a cell. Inosine at concentrations as low as 40 nM can support the entire energy requirement of pig erythrocytes [41] [42] [43] , and has been shown to support partially the cellular energy demands in a variety of other tissues [44] [45] [46] [47] [48] . In this context, inosine can be acted on by nucleoside phosphorylase to yield hypoxanthine and ribose 1-phosphate [39] , with this latter product entering glycolysis via the pentose phosphate pathway.
Compartmentalization of ADA may provide a pathway of metabolism that is advantageous under certain conditions. At low adenosine concentrations, adenosine is primarily phosphorylated in the cytosol by adenosine kinase, which has a much lower Km for adenosine than does ADA [39, 49] . In contrast, at high adenosine concentrations, adenosine inhibits adenosine kinase activity, allowing deamination by ADA to be the major route of adenosine metabolism [39, 49] . By compartmentalizing ADA activity within lysosomes, however, adenosine deamination could occur without competition by the kinase reaction. The inosine thus formed within lysosomes can be transported to the cytosol and converted by nucleoside phosphorylase into hypoxanthine and ribose 1-phosphate, which can be used to support cellular energy requirements, which may be particularly important under conditions of nutritional deprivation. Although lysosomal ADA constitutes only 10 % of the total ADA activity of human fibroblasts, this compartmentalization, allowing ADA to function in the absence of adenosine kinase competition, may permit lysosomal ADA to play a significant role in overall adenosine deamination within the cell under normal conditions.
Hence the concept of lysosomes as supplying critical nutrients within the cell may be further expanded by the finding of ADA activity within this compartment.
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